NEUP
Neuphoria Therapeutics Inc
NASDAQ: NEUP · HEALTHCARE · BIOTECHNOLOGY
$5.27
+1.54% today
Updated 2026-04-30
Market cap
$27.76M
P/E ratio
—
P/S ratio
1.85x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$4 – $21
Volume
0.1M
Neuphoria Therapeutics Inc (NEUP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.75M | $-6.30M | $-6.61M | $-4.99M | $-7.10M | $-8.98M | $-4.01M | $-10.05M | $-12.91M | $4.94M | $-15.36M | $-1.44M | $-15.02M | $-10.91M | $-2.68M | $-5.66M | $-14.97M | $-9.85M | $-14.68M | $77.23M |
| Capital expenditures | $133165.00 | $114500.00 | $369127.00 | $89055.00 | $39011.00 | $81104.00 | $663975.00 | $157585.00 | $203926.00 | $649080.00 | $146897.00 | $190199.00 | $358109.00 | $69282.00 | $5293.00 | $1102.00 | $1062.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $1.68M | $1.28M | $763174.00 | $446094.00 | $662991.00 | $662.89M |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $38035.00 | $983011.00 | $1.95M | $1.35M | $814808.00 | $163.77M |
| Free cash flow | $-3.88M | $-6.42M | $-6.98M | $-5.08M | $-7.14M | $-9.06M | $-4.68M | $-10.21M | $-13.12M | $4.29M | $-15.51M | $-1.63M | $-15.38M | $-10.98M | $-2.69M | $-5.67M | $-14.97M | $-9.85M | $-14.68M | $77.23M |
| Investing cash flow | $-121370.00 | $-114500.00 | $271351.00 | $142423.00 | $358616.00 | $354682.00 | $7.02M | $-628473.00 | $330211.00 | $-227635.00 | $824637.00 | $733055.00 | $59682.00 | $138423.00 | $-134078.00 | $-60261.00 | $427675.00 | $317414.00 | — | — |
| Financing cash flow | $-266118.00 | $12.32M | $-198454.00 | $2.68M | $12.38M | $12.92M | $-1.59M | $14.36M | $573848.00 | $9.43M | $24.79M | $-1.60M | $1.94M | $3.05M | $-3.68M | $23.71M | $18.57M | $2.60M | $15.11M | $1.53B |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |